Status:
COMPLETED
A Study Comparing Non Myeloablative (Flu-TBI) and Reduced Intensity (FLU-BU-ATG) Conditioning in Allogenic Transplantation
Lead Sponsor:
Institut Paoli-Calmettes
Conditions:
Allograft
Allogeneic Cell Transplantaion
Eligibility:
All Genders
18-65 years
Phase:
PHASE2
Brief Summary
This study is a prospective comparison between 2 popular regimens based on reduced intensity or non-myeloablative approaches to define the optimal myeloablative and/or immu-nonsuppressive association ...
Eligibility Criteria
Inclusion
- hematological malignancy or solid tumor,
- eligible for non myeloablative allogenic transplantation,
- aged between 18 and 65,
- with a suitable HLA identical sibling
Exclusion
- contra-indication to allogenic transplantation
- pregnant women or breast feeding
- active infection
Key Trial Info
Start Date :
November 1 2002
Trial Type :
INTERVENTIONAL
Allocation :
ACTUAL
End Date :
February 1 2013
Estimated Enrollment :
148 Patients enrolled
Trial Details
Trial ID
NCT00894049
Start Date
November 1 2002
End Date
February 1 2013
Last Update
January 1 2014
Active Locations (5)
Enter a location and click search to find clinical trials sorted by distance.
1
CHU
Bordeaux Pessac, France
2
CHU
Clermont-Ferrand, France
3
CHU
Lyon, France
4
Institut Paoli-Calmettes
Marseille, France